AU-15330 CAS No.2380274-50-8
AU-15330 CAS No.2380274-50-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2436 | 5mg | 380.00 | + Add to cart |
|
| R-R-2436 | 10mg | 640.00 | + Add to cart |
|
|
|
||||
Product description
AU-15330/CAS No.2380274-50-8 is a proteolysis-targeting chimera (PROTAC) degrader of the SWI/SNF ATPase subunits, SMARCA2 and SMARCA4. AU-15330 induces potent inhibition of tumour growth in xenograft models of prostate cancer and synergizes with the AR antagonist enzalutamide. AU-15330 induces disease remission in castration-resistant prostate cancer (CRPC) models without toxicity.
| Appearance | N/A |
|---|---|
| Molecular Weight | 755.93 |
| Purity | >90% |
| CAS | 2380274-50-8 |
| Formula | C39H49N9O5S |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of AU-15330 CAS No.2380274-50-8
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


